Literature DB >> 21310753

The inhibition of anaplastic lymphoma kinase in non-small cell lung tumours with the ALK rearrangement may result in tumour shrinkage.

Louise Hancock.   

Abstract

Entities:  

Year:  2011        PMID： 21310753     DOI： 10.1136/thx.2011.159467

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  2 in total

Review 1.  Lung cancer biomarkers, targeted therapies and clinical assays.

Authors:  Jai N Patel; Jennifer L Ersek; Edward S Kim
Journal:  Transl Lung Cancer Res       Date:  2015-10

2.  Identification and therapeutic evaluation of ALK rearrangements in non-small-cell lung cancer.

Authors:  Ruiying Zhao; Lianying Guo; Bo Zhang; Jikai Zhao; Chan Xiang; Shengnan Chen; Jinchen Shao; Lei Zhu; Min Ye; Yuchen Han
Journal:  J Pathol Clin Res       Date:  2022-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.